Vaccines as Social Goods
Will COVID be an opportunity for a comprehensive strategy?
DOI:
https://doi.org/10.24215/26183188e047Keywords:
vaccines, Social Goods, pharmaceutical multinationals, local production of vaccinesAbstract
Argentina went from having one of the most complete National Vaccination Calendars in the world to having in recent years a shortage of vaccines to assist the population. This work analyzes, on the one hand, the changes that have occurred in the production of vaccines at an international level, with the monopoly consolidation of a group of multinational pharmaceutical companies. On the other hand, the situation in Argentina is described, its interrelation with the international market and the actors involved. A comprehensive strategy is proposed to address the development and production of vaccines, taking advantage of the experience and scientific and technological capacities the country counts with. Some recommendations are suggested in relation to the global vaccine market and the emergence of COVID and a series of questions are left open to be solved in order to achieve access to this social good for the entire population.
Downloads
Metrics
References
AIMFA (2017). Mercado de Vacunas 2017 a nivel mundial. Agrupación de Investigación y Marketing Farmacéutico. Recuperado de: https://www.aimfa.es/mercado-vacunas-2017-nivel-mundial/ (acceso: 20-09-2019).
Arrow, K. (1962). The Economic Implications of Learning by Doing. Review of Economic Studies, Vol. XXIX, N° 80, pp. 155-172.
Congreso de la Nación Argentina (2 de diciembre de 2016). Presupuesto Nacional 2017. Ley 27.341 de 2016. Recuperado de: https://www.economia.gob.ar/onp/documentos/presutexto/ley2017/ley/ley2017.pdf
Coriat, B. & Orsi, F. (2007). Derechos de Propiedad Intelectual e Innovación, en: Documentos para seminarios n.º 12 Documento para el seminario Propiedad intelectual e innovación, Buenos Aires, 3 al 6 de diciembre 2007. CEIL, PIETTI, CONICET.
Corvalán, D. (2017). Des-aprendizaje y pérdida de capacidades locales. El Calendario Nacional de Vacunación en Argentina. Ciencia, Docencia y Tecnología. vol. 28, N° 54.
Corvalán, D. (2019). Las vacunas que faltan. Agencia TSS – Universidad Nacional de San Martín. https://www.unsam.edu.ar/tss/las-vacunas-que-faltan/ (acceso: 20-09-2019).
Gutman, G. & Lavarello, P. (2014). Biotecnología Industrial en Argentina. Estrategias empresariales frente un nuevo paradigma. Gran Aldea Editores.
Homma, A.; Di Fabio, J. L. & De Quadros, C. (1998). Los laboratorios públicos productores de vacunas: el nuevo paradigma. Rev. Panamericana de Salud Pública 4.
Lundvall, B-A. (1988). Innovation as an Interactive Process- from User-Producer Interaction to the National System of Innovation. Technical Change and Economic Theory. Londres, Pinter Publishers,pp. 349-369.
OMS (2 de octubre de 2020). Draft landscape of COVID-19 candidate vaccines. Organización Mundial de la Salud. Recuperado de: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (acceso: 2/10/20).
Rosenberg, N. (1982). Inside the Black Box: Technology and Economics. Cambridge: Cambridge University Press.
Santos, G. & Thomas, H. (2018). Producción pública de medicamentos: desafíos para una política estratégica en materia de salud. Ciencia, Tecnología y Política 1(1), 007. https://doi.org/10.24215/26183188e007.
Published
How to Cite
Issue
Section
License
The authors whose texts are published in this Journal surrender their ownership rights in favour of the editor in a non exclusive manner, i.e. the authors can enter into other independent and additional contracts to publish their text, e.g. including it in an institutional repository, thematic or otherwise, publish it in a book, or others, as long as it is overtly stated that the work was first published in this Journal.
The responsibility for each published paper as regards its content relies exclusively on its authors, holding the editors harmless for any legal liabilities.
The texts of the Journal shall be published under the Creative Commons 4.0 BY-NC-SA license. Therefore, the editors are free to:
1) Share, copy and redistribute the material using any means or format.
2) Adapt, remix, transform and create from the material, under the following conditions:
a) Attribution — credit to this work must be given in an appropriate manner, providing a link to the license and indicating if changes have been made.
b) Non-Commercial Use — no use may be made of the published material for commercial purposes.
c) Share Equal — Authors remixing, transforming or creating from the material must distribute their contribution under the same license as the original.
